Dividend Received from Consumer Healthcare JV
Intel Dividend Received from Consumer Healthcare JV remained flat by 0.0% to $167.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 35.9%, from $261.75M to $167.75M. Over 4 years (FY 2021 to FY 2025), Dividend Received from Consumer Healthcare JV shows an upward trend with a 3.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher dividends indicate strong performance of the underlying joint venture, contributing positively to the bank's non-interest income.
Detailed definition
Cash inflows representing the bank's share of profits distributed from a joint venture or equity-method investment. This...
Peer comparison
Specific to companies with equity-method investments; peers report this as income from unconsolidated subsidiaries.
pfe_dividend_received_from_consumer_healthcare_jvHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $581.00M | $4.96B | $472.00M | $1.05B | $671.00M |
| YoY Change | — | +753.9% | -90.5% | +121.8% | -35.9% |
Dividend Received from Consumer Healthcare JV at Other Companies
Frequently Asked Questions
- What is Intel's dividend received from consumer healthcare jv?
- Intel (INTC) reported dividend received from consumer healthcare jv of $167.75M in Q4 2025.
- How has Intel's dividend received from consumer healthcare jv changed year-over-year?
- Intel's dividend received from consumer healthcare jv decreased by 35.9% year-over-year, from $261.75M to $167.75M.
- What is the long-term trend for Intel's dividend received from consumer healthcare jv?
- Over 4 years (2021 to 2025), Intel's dividend received from consumer healthcare jv has grown at a 3.7% compound annual growth rate (CAGR), from $581.00M to $671.00M.
- What does dividend received from consumer healthcare jv mean?
- Cash received as a share of profits from a joint venture or equity investment.